These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Five years on...and four challenges for the pharmaceutical industry. Nat Rev Drug Discov; 2007 Jan; 6(1):3. PubMed ID: 17269156 [No Abstract] [Full Text] [Related]
5. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening]. Schirlin D; Galvan M; Le Fur G Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426 [TBL] [Abstract][Full Text] [Related]
6. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related]
7. Pharmacogenetics and drug metabolism. Ball S; Borman N Nat Biotechnol; 1997 Oct; 15(10):925-6. PubMed ID: 9335033 [No Abstract] [Full Text] [Related]
8. Advancing in the face of conventional wisdom. Lanzara R Drug Discov Today; 2004 Feb; 9(3):110-1. PubMed ID: 14960386 [No Abstract] [Full Text] [Related]
9. Pharma's year of trouble and strife. Frantz S Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339 [No Abstract] [Full Text] [Related]
10. Drug trials, gender, and Dr. Spilker: what is fad and what is science? Legato MJ J Gend Specif Med; 1999; 2(5):14, 17. PubMed ID: 11252829 [No Abstract] [Full Text] [Related]
11. Drugs in pregnancy: acknowledging challenges--finding solutions. Koren G; MacLeod S; Davis D Can J Clin Pharmacol; 2007; 14(1):e2-4. PubMed ID: 17213506 [No Abstract] [Full Text] [Related]
12. An integrated, multidisciplinary approach for drug safety assessment. Li AP Drug Discov Today; 2004 Aug; 9(16):687-93. PubMed ID: 15341779 [No Abstract] [Full Text] [Related]
13. An audience with... Jan M. Lundberg. Lundberg JM Nat Rev Drug Discov; 2005 Jun; 4(6):452. PubMed ID: 15959949 [No Abstract] [Full Text] [Related]
14. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Baillie TA Chem Res Toxicol; 2008 Jan; 21(1):129-37. PubMed ID: 18052111 [TBL] [Abstract][Full Text] [Related]
15. Multicomponent reactions in solid-phase synthesis. Banfi L; Guanti G; Riva R; Basso A Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522 [TBL] [Abstract][Full Text] [Related]
16. High-throughput and parallel screening methods in asymmetric hydrogenation. Jäkel C; Paciello R Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304 [No Abstract] [Full Text] [Related]
17. Realism in drug discovery-could Cassandra be right? Horrobin DF Nat Biotechnol; 2001 Dec; 19(12):1099-100. PubMed ID: 11731767 [No Abstract] [Full Text] [Related]
19. Global trends in the pharmaceutical industry. Albers-Schönberg G P R Health Sci J; 2002 Jun; 21(2):85-9. PubMed ID: 12166029 [No Abstract] [Full Text] [Related]
20. Evaluation and recommendations on adaptive dose-ranging trials: highlights from the PhRMA Adaptive Dose-Ranging Studies Working Group. Pinheiro J J Clin Pharmacol; 2010 Sep; 50(9 Suppl):47S-49S. PubMed ID: 20881216 [No Abstract] [Full Text] [Related] [Next] [New Search]